A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Jasmine Zain, David Claxton, Joseph Tuscano, Edward M. Newman, David R Gandara, Primo N Lara

Research output: Contribution to journal › Article

Original languageEnglish (US)
JournalBritish Journal of Haematology
DOIs
StateAccepted/In press - 2016

Fingerprint

Recombinant Fusion Proteins
Vascular Endothelial Growth Factor Receptor
Myelodysplastic Syndromes
Vascular Endothelial Growth Factor A
Clinical Trials
Neoplasms
aflibercept

Keywords

  • Clinical trials
  • Myelodysplastic syndrome
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Hematology

Cite this

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. / Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R; Lara, Primo N.

In: British Journal of Haematology, 2016.

Research output: Contribution to journal › Article

Kirschbaum, MH, Frankel, P, Synold, TW, Zain, J, Claxton, D, Tuscano, J, Newman, EM, Gandara, DR & Lara, PN 2016, 'A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study', British Journal of Haematology. https://doi.org/10.1111/bjh.14333
Kirschbaum MH, Frankel P, Synold TW, Zain J, Claxton D, Tuscano J et al. A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study. British Journal of Haematology. 2016. https://doi.org/10.1111/bjh.14333
Kirschbaum, Mark H. ; Frankel, Paul ; Synold, Timothy W. ; Zain, Jasmine ; Claxton, David ; Tuscano, Joseph ; Newman, Edward M. ; Gandara, David R ; Lara, Primo N. / A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. In: British Journal of Haematology. 2016.
@article{3a9ad6cc23374cdab037c2c3b2659ee5,
title = "A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study",
keywords = "Clinical trials, Myelodysplastic syndrome, Vascular endothelial growth factor",
author = "Kirschbaum, {Mark H.} and Paul Frankel and Synold, {Timothy W.} and Jasmine Zain and David Claxton and Joseph Tuscano and Newman, {Edward M.} and Gandara, {David R} and Lara, {Primo N}",
year = "2016",
doi = "10.1111/bjh.14333",
language = "English (US)",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome

T2 - A California Cancer Consortium Study

AU - Kirschbaum, Mark H.

AU - Frankel, Paul

AU - Synold, Timothy W.

AU - Zain, Jasmine

AU - Claxton, David

AU - Tuscano, Joseph

AU - Newman, Edward M.

AU - Gandara, David R

AU - Lara, Primo N

PY - 2016

Y1 - 2016

KW - Clinical trials

KW - Myelodysplastic syndrome

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84997611337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997611337&partnerID=8YFLogxK

U2 - 10.1111/bjh.14333

DO - 10.1111/bjh.14333

M3 - Article

C2 - 27650362

AN - SCOPUS:84997611337

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -

Access to Document